Authors
Latest:
R&D for NMOSD TherapiesDrs Mirla Avila, Mitzi Williams, Michael Levy, and Michael Yeaman comment on research and development priorities for clinical care and emerging therapies for NMOSD.
Latest:
Acute and Preventative Migraine Treatment: Advice for NeurologistsDr David Kudrow shares some advice for community neurologists on the acute and preventive treatment of migraine.
Latest:
Interdisciplinary Care Teams in Epilepsy Care: Lucretia Long, APRN-CNPThe associate clinical professor of neurology at OSU Wexner Medical Center discussed the state of interdisciplinary care for individuals with epilepsy, and how these care teams operate. [WATCH TIME: 2 minutes]
Latest:
Uncovering the Impact of Social Determinants on the Risk of Alzheimer Disease: Michael Yassa, PhDThe professor of neurology at the University of California, Irvine, talked about social determinants of health in Alzheimer disease and the importance of having diverse populations in clinical trials. [WATCH TIME: 4 minutes]
Latest:
Sex Dependent Decreases in REM Sleep After TBI and the Impact it May Have on RecoveryGrace Griesbach, PhD, the national director of clinical research for Centre for Neuro Skills, discussed the impact of REM sleep on memory following traumatic brain injury and the importance of considering sex as a biological variable.
Latest:
Switching MG Treatment Due to Adverse Events or Poor Disease ControlExpert neurologists share approaches to switching MG treatment due to either poor disease control or adverse events.
Latest:
Flaws in Assessment Scales for Neuromuscular Conditions: Laurent Servais, MD, PhDThe professor of pediatric neuromuscular diseases at the University of Oxford provided commentary on the commonly used scales to assess neuromuscular function and where inconsistencies have been observed. [WATCH TIME: 7 minutes]
Latest:
Stephen L. Hauser, MD: Fenebrutinib and BTK Inhibition in Progressive MSThe director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.
Latest:
Debunking Myths of Migraine’s Role in Dementia: Olivia Begasse de Dhaem, MD, FAHSThe headache specialist at Hartford Healthcare Headache Center emphasized the importance of avoiding unnecessary fear surrounding the potential link between migraine and dementia, as current evidence does not strongly support it being a significant risk factor. [WATCH TIME: 2 minutes]
Latest:
Immunization Strategy as a Potential Approach to Slowing Cognitive Decline in AD: Jean-Cosme Dodart, PhDThe senior vice president of research at Vaxxinity discussed recently published trial findings on a novel vaccine that targets Alzheimer disease and triggers the production of antibodies against toxic amyloid-ß peptides. [WATCH TIME: 9 minutes]
Latest:
Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhDThe director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]
Latest:
AUPN Leadership Minute Episode 23: Time Savers for ChairsEpisode 23 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Jun Li, MD, PhD, of Houston Methodist Hospital. [WATCH TIME: 3 minutes]
Latest:
Future Research on Subarachnoid Hemorrhage: Guilherme Dabus, MDThe codirector of interventional neuroradiology and vice-chief of the department of neuroscience at Baptist Health Miami Neuroscience Institute discussed the questions that still remain with identifying and treating subarachnoid hemorrhage. [WATCH TIME: 3 minutes]
Latest:
Machine Learning Techniques for Predicting Stroke Risk in Adults: Michael Pencina, PhDThe vice dean for data science at Duke University School of Medicine spoke about the major disparities observed in models that assess stroke risk. [WATCH TIME: 4 minutes]
Latest:
Navigating the Transition From Pediatric to Adult MS Care: Yolanda Wheeler, PhD, CPNP-AC, MSCNThe assistant professor at the University of Alabama at Birmingham discussed the transition from pediatric to adult care for patients with multiple sclerosis as well as the challenges presented in diagnosis, treatment, and understanding the long-term impact of the disease. [WATCH TIME: 5 minutes]
Latest:
Use of Narcolepsy Treatments in Different Patients: Part 1Drs Thorpy, Dogan, Doghramji, and Kushida detail which medications to use in various patients with narcolepsy.
Latest:
Shifting the Paradigm of Clinical Research in Alzheimer Disease With the COCOA Trial: Jared Roach, MD, PhDThe senior research scientist at the Institute for Systems Biology spoke about changing the perception of clinical trials for Alzheimer disease research based on the COCOA trial presented at the 2022 CTAD conference. [WATCH TIME: 2 minutes]
Latest:
Optimizing Integrative Wellness Strategies for MS Through Research: Kathy Zackowski, PhD, OTRThe senior director of patient management, care, and rehabilitation at the National Multiple Sclerosis Society discussed the steps needed to take to improve relatively new wellness strategies. [WATCH TIME: 3 minutes]
Latest:
Preserving Cognitive Status in Pediatric Multiple Sclerosis: Kimberly O’Neill, MDThe pediatric neuroimmunology fellow at NYU Langone provided perspective on a study presented at AAN 2023 comparing cognitive trajectories of pediatric and adult multiple sclerosis. [WATCH TIME: 3 minutes]
Latest:
Potential for Combination Approaches in Multiple Sclerosis and Role of CNM-Au8: Michael Barnett, PhD, MBBS, FRACPThe senior academic at the University of Sydney provided perspective on the role of CNM-Au8 in MS among a crowded treatment landscape, and the need for adjuvant treatments that address lingering lesion burden. [WATCH TIME: 3 minutes]
Latest:
Inspiring and Educating Young Medical Professionals to Parkinson Disease Care: Eli PollardThe chief training and education officer at the Parkinson’s Foundation discussed the inclusion of various medical professionals that assist in Parkinson disease care, and the need to provide access to educational tools to inform clinicians. [WATCH TIME: 5 minutes]
Latest:
Understanding Neurological Manifestations in Long COVID: Svetlana Blitshteyn, MD, FAANThe director of Dysautonomia Clinic discussed neurological manifestations of Long COVID, such as headache, cognitive complaints, and sleep problems, and how they are similar to those seen with migraine comorbidities. [WATCH TIME: 5 minutes]
Latest:
Targeting Memory and Learning Deficits in MS Through Combined Cognitive Rehabilitation and Exercise With Virtual Reality: Carly Wender, PhDThe research scientist at Kessler Foundation discussed a recently funded study focused on improving memory and learning deficits in patients with multiple sclerosis by combining a cognitive rehabilitation program with a cycling initiative enriched with virtual reality elements. [WATCH TIME: 7 minutes]
Latest:
Connecting ALS: How New Drug Coverage Decisions Are MadeIn this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
Latest:
Roundtable: Building a Greater Understanding for Dravet SyndromeA duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.
Latest:
AI in Multiple Sclerosis: Expert Insights Into Limitations and OpportunitiesExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
Personalized Treatment Approaches of Myopathies Based on Antibodies: Suur Bilicier, MDThe associate professor of neurology at the University of Texas Health Science Center at Houston talked about advances in the classification of inflammatory myopathies at the recently concluded 2023 MDA conference. [WATCH TIME: 4 minutes]
Latest:
Navigating Treatment Decision-Making in Multiple SclerosisIn a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?
Latest:
Advanced Imaging for Extended Stroke TreatmentWith many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.
